120 related articles for article (PubMed ID: 2071269)
1. Comparative bioavailability of two tablet formulations of diclofenac sodium in normal subjects.
Hasan MM; Najib NM; Rawashdeh NM; Sallam EN; Shubair MS; Alawneh Y
Int J Clin Pharmacol Ther Toxicol; 1991 May; 29(5):178-83. PubMed ID: 2071269
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability and pharmacokinetic properties of 2 sustained-release formulations of diclofenac sodium, Voltaren vs inflaban: effect of food on inflaban bioavailability.
Zmeili S; Hasan M; Najib N; Sallam E; Deleq S; Shubair M
Int J Clin Pharmacol Ther; 1996 Dec; 34(12):564-70. PubMed ID: 8996854
[TBL] [Abstract][Full Text] [Related]
3. Comparative bioavailability and in vitro characterization of two brands of diclofenac sodium enteric-coated tablets.
el-Sayed Y; Suleiman MS; Hasan M; Najib N; Muti H; Abdulhameed M
Int J Clin Pharmacol Ther Toxicol; 1988 Oct; 26(10):487-91. PubMed ID: 3235214
[TBL] [Abstract][Full Text] [Related]
4. A comparative bioavailability study on two sustained-release formulations of diclofenac sodium following a single dose administration.
Hasan MM; Najib NM; Muti H
Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):387-91. PubMed ID: 8225684
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro dissolution and in vivo bioequivalence of two diclofenac enteric coated formulations.
Basmenji S; Valizadeh H; Zakeri-Milani P
Arzneimittelforschung; 2011; 61(10):566-70. PubMed ID: 22164964
[TBL] [Abstract][Full Text] [Related]
6. Comparative bioavailability study of a generic sustained release diclofenac sodium tablet.
Magosso E; Yuen KH; Choy WP; Ling SS; Ng BH; Ur-Rahman N; Wong JW
Med J Malaysia; 2004 Aug; 59(3):352-6. PubMed ID: 15727381
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
8. Comparative bioavailability of two suspension formulations of potassium diclofenac in healthy male volunteers.
Mendes GB; Franco LM; Moreno RA; Fernandes AG; Muscara MN; de Nucci G
Int J Clin Pharmacol Ther; 1994 Mar; 32(3):131-5. PubMed ID: 8205374
[TBL] [Abstract][Full Text] [Related]
9. Comparative bioavailability of slow release diclofenac (Voveran SR) with enteric coated tablet and internationally used Voltaren Retard.
Sahajwalla CG; Bhatt AD; Bhatia SC; Bakshi R; Doshi KJ; Banavalikar MM; Bharucha ED; Marthak KV; Shah NN; Gupta KC
J Assoc Physicians India; 1991 Jul; 39(7):546-8. PubMed ID: 1800501
[TBL] [Abstract][Full Text] [Related]
10. Formulation and in vitro and in vivo availability of diclofenac sodium enteric-coated beads.
Hosny EA; el-Mahrouk GM; Gouda MW
Drug Dev Ind Pharm; 1998 Jul; 24(7):661-6. PubMed ID: 9876511
[TBL] [Abstract][Full Text] [Related]
11. Comparative bioavailability of two enteric-coated capsules of omeprazole in healthy volunteers.
Garg SK; Chugh Y; Tripathi SK; Kumar N; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1993 Feb; 31(2):96-9. PubMed ID: 8458683
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the pharmacokinetics and pharmacodynamics of two commercial products containing glibenclamide.
el-Sayed YM; Suleiman MS; Hasan MM; Abdel-Hamid ME; Najib NM; Sallam ES; Shubair MS
Int J Clin Pharmacol Ther Toxicol; 1989 Nov; 27(11):551-7. PubMed ID: 2515159
[TBL] [Abstract][Full Text] [Related]
13. [Relative bioavailability of diclofenac after a single administration of a new multiple-unit formulation of enteric-coated pellets].
Walter K; von Nieciecki A
Arzneimittelforschung; 2001; 51(8):643-50. PubMed ID: 11556125
[TBL] [Abstract][Full Text] [Related]
14. [Biological availability of gastric juice-resistant coated diclofenac preparations. 1. Bioavailability study following a single administration of a multiple-unit formulation in comparison with a single-unit formulation].
Scheidel B; Blume H; Walter K; von Nieciecki A; Babej-Dölle RM
Arzneimittelforschung; 1993 Nov; 43(11):1211-5. PubMed ID: 8292067
[TBL] [Abstract][Full Text] [Related]
15. Comparative bioavailability of single doses of tablet formulations of cetirizine dihydrochloride in healthy male volunteers.
Muscará MN; de Nucci G
Int J Clin Pharmacol Ther; 1995 Jan; 33(1):27-31. PubMed ID: 7711987
[TBL] [Abstract][Full Text] [Related]
16. Comparative bioavailability of a dispersible formulation of diclofenac and finding of double plasma peaks.
Macía MA; Frias J; Carcas AJ; Guerra P; Valiente R; Lucero ML
Int J Clin Pharmacol Ther; 1995 Jun; 33(6):333-9. PubMed ID: 7582384
[TBL] [Abstract][Full Text] [Related]
17. A two-way cross-over bioequivalence study comparing two products of diclofenac sodium suppositories in healthy human volunteers.
Hasan M; Otoom S; Najib N; Sallam el-S
Basic Clin Pharmacol Toxicol; 2004 Dec; 95(6):263-5. PubMed ID: 15569270
[TBL] [Abstract][Full Text] [Related]
18. Comparative pharmacokinetic analysis of a novel sustained-release dosage form of diclofenac sodium in healthy subjects.
Raz I; Hussein Z; Samara E; Ben-David J
Int J Clin Pharmacol Ther Toxicol; 1988 May; 26(5):246-8. PubMed ID: 3410601
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro and in vivo evaluations of oral sustained-release formulations of diclofenac sodium in beagle dogs.
Medeiros DC; Mazon-Cardoso T; Lemos-Senna E; Poli A
Pharmazie; 2009 Oct; 64(10):648-52. PubMed ID: 19947166
[TBL] [Abstract][Full Text] [Related]
20. [Comparative bioavailability and pharmacokinetics of Dolotren retard and Dolotren].
Honorato J; Montes B; Suárez J; Lucero ML; Valiente R
Rev Med Univ Navarra; 1992; 37(1):7-16. PubMed ID: 1626168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
